云南中医学院学报
雲南中醫學院學報
운남중의학원학보
JOURNAL OF YUNNAN COLLEGE OF TRADITIONAL CHINESE MEDICINE
2015年
3期
51-54
,共4页
王晋平%李伟茜%张海燕%周路%姜薇%唐农
王晉平%李偉茜%張海燕%週路%薑薇%唐農
왕진평%리위천%장해연%주로%강미%당농
益肺宣肺降浊胶囊%轻中度%血管性痴呆%随机对照%临床观察
益肺宣肺降濁膠囊%輕中度%血管性癡呆%隨機對照%臨床觀察
익폐선폐강탁효낭%경중도%혈관성치태%수궤대조%림상관찰
Yifei Xuanfei Jiangzhuo Capsule%mild-to-moderate%vascular dementia%randomized controlled%clinical observation
目的:观察益肺宣肺降浊胶囊治疗轻中度血管性痴呆(VD)的临床疗效及安全性。方法采用随机双盲对照试验的设计方法,将80例患者分为益肺宣肺降浊胶囊治疗组(治疗组,40例)和吡拉西坦胶囊对照组(对照组,40例),观察治疗前后两组患者中医证候疗效、中医证候积分(SDSVD)、洛文斯顿作业疗法评定(LOTCA评定)、日常生活活动能力量表(ADL)的变化以及该药物的安全性。结果治疗后治疗组中医证候疗效改善优于对照组(P<0.05);治疗后2组患者SDSVD、LOTCA评定及ADL变化均较治疗前明显改善(P<0.05),治疗组较对照组改善更为明显(P<0.05),且无明显不良反应。结论益肺宣肺降浊胶囊能有效地改善VD患者的SDSVD、LOTCA评定及ADL,有肯定的临床疗效,且安全可靠,值得临床推广应用及进一步深化研究。
目的:觀察益肺宣肺降濁膠囊治療輕中度血管性癡呆(VD)的臨床療效及安全性。方法採用隨機雙盲對照試驗的設計方法,將80例患者分為益肺宣肺降濁膠囊治療組(治療組,40例)和吡拉西坦膠囊對照組(對照組,40例),觀察治療前後兩組患者中醫證候療效、中醫證候積分(SDSVD)、洛文斯頓作業療法評定(LOTCA評定)、日常生活活動能力量錶(ADL)的變化以及該藥物的安全性。結果治療後治療組中醫證候療效改善優于對照組(P<0.05);治療後2組患者SDSVD、LOTCA評定及ADL變化均較治療前明顯改善(P<0.05),治療組較對照組改善更為明顯(P<0.05),且無明顯不良反應。結論益肺宣肺降濁膠囊能有效地改善VD患者的SDSVD、LOTCA評定及ADL,有肯定的臨床療效,且安全可靠,值得臨床推廣應用及進一步深化研究。
목적:관찰익폐선폐강탁효낭치료경중도혈관성치태(VD)적림상료효급안전성。방법채용수궤쌍맹대조시험적설계방법,장80례환자분위익폐선폐강탁효낭치료조(치료조,40례)화필랍서탄효낭대조조(대조조,40례),관찰치료전후량조환자중의증후료효、중의증후적분(SDSVD)、락문사돈작업요법평정(LOTCA평정)、일상생활활동능역량표(ADL)적변화이급해약물적안전성。결과치료후치료조중의증후료효개선우우대조조(P<0.05);치료후2조환자SDSVD、LOTCA평정급ADL변화균교치료전명현개선(P<0.05),치료조교대조조개선경위명현(P<0.05),차무명현불량반응。결론익폐선폐강탁효낭능유효지개선VD환자적SDSVD、LOTCA평정급ADL,유긍정적림상료효,차안전가고,치득림상추엄응용급진일보심화연구。
Objective Observation of the clinical therapeutic effect of Yifei Xuanfei Jiangzhuo Capsule on mild-to-moderate vascular dementia to explore its the degree of reaction of chemotherapy. Methods Eighty patients with mild-to-moderate vascular dementia were randomly divided into treatment group and control group with randomized-double blind and controlled design method , each group for 40 cases,respectively. The treatment group was accepted Yifei Xuanfei Jiangzhuo Capsule,while the control group was accepted Piracetam by oral. The changes such as the curative effect of TCM syndrome,The syndroms integral of TCM symptom (SDSVD),Loewenstein Occupational Therapy Cognitive Assessment(LOTCA),The daily living ability(ADL),and The safety of the drug were observed. Results The curative effect of TCM syndrome,SDSVD、LOTCA,and ADL in 2 groups above were both signi cantly higher than those before treatment(P<0.05),with the treatment group being more obvious than the control group(P<0.05). Conclusion Yifei Xuanfei Jiangzhuo Capsule could effectively improve the SDSVD、LOTCA,and the curative effect of TCM syndrome on patients with mild-to-moderate vascular dementia,It obtains definite curative effect,and deserves to be spread and is studied further in the clinic.